Finding the right tests…
Emergency services available 24 x 7
Emergency services available 24 x 7
Finding the right tests…
Molecular
Truenat H1N1 tests for influenza A (H1N1) using a portable, chip-based real-time PCR platform developed in India and originally built for point-of-care TB testing before being expanded to other infections. It looks for the virus's genetic material in a nasal or throat swab, the same molecular approach used in other RT-PCR flu tests, rather than the viral proteins a rapid antigen test detects. Because the device is compact and battery-operated, it can run in smaller centres rather than requiring a sample to be sent to a large, centralised virology lab. It's ordered when a doctor needs a more dependable result than a quick antigen test can reliably provide.
A positive result confirms active influenza A (H1N1) infection and helps your doctor decide on antiviral treatment, precautions around others, and whether other causes of your symptoms need to be considered. A negative result makes H1N1 less likely but, as with any respiratory PCR test, can be affected by how the swab was collected and how many days into the illness you are; a swab taken too early or with too little sample can miss a real infection. Molecular tests like this one are generally more sensitive than rapid antigen flu tests, which commonly miss a meaningful share of true infections.
Truenat is a portable, battery-powered, chip-based real-time PCR system built in India, originally developed for point-of-care tuberculosis testing and later expanded to cover other infections, including influenza A/H1N1, dengue, and COVID-19, on the same basic equipment. Because the device doesn't need a full central lab setup around it, it has been deployed widely across primary and community health centres as well as private labs and hospitals in India.
A rapid antigen test looks for viral proteins and gives a same-visit answer, but CDC data on influenza testing shows antigen tests run meaningfully less sensitive than molecular methods, commonly missing infections more often than PCR-based tests do. Truenat H1N1, like standard RT-PCR, looks for the virus's genetic material directly, which is why doctors reach for it when a dependable result matters, such as before antiviral treatment or in a person at higher risk of complications.
This test confirms whether influenza A (H1N1) is present in your sample at collection. It doesn't tell your doctor how severe your illness will be, and a negative result taken very early in the illness, before the virus has built up in your nose and throat, can still occur even with a real infection. That's part of why doctors weigh the result alongside your symptoms and timing, rather than reading it alone.
It's a portable, battery-operated device that runs real-time PCR on a small chip, originally developed in India for point-of-care TB testing and later expanded to other infections. It looks for a pathogen's genetic material directly from a patient sample.
A rapid antigen test looks for viral proteins and is generally less sensitive than molecular methods, according to CDC data on influenza testing. Truenat H1N1, like standard RT-PCR, looks for the virus's genetic material directly, which makes it a more dependable option when a confirmed result matters.
Yes, it runs on the same chip-based, portable PCR platform used for TB and COVID-19 testing in India, just with a different chip designed to detect influenza A (H1N1) genetic material instead.
This page is general information about the test, not medical advice. Your own report's reference ranges apply — please discuss your results with your doctor.
It's possible, especially if the swab was taken very early in the illness or didn't collect enough sample. As with any respiratory PCR test, your doctor considers the result alongside your symptoms and timing rather than reading it alone.
That depends on your symptoms, how long you've been ill, and your individual risk factors. Ask your doctor about whether antiviral treatment is appropriate for you.
Because the device is compact and doesn't need a full central lab setup around it, it can be run closer to where you're being seen rather than requiring your sample to be sent elsewhere. Ask your doctor or the centre about testing options available to you.